| Absorption |
| Blood-Brain Barrier | BBB- | 0.9704 |
| Human Intestinal Absorption | HIA- | 0.7776 |
| Caco-2 Permeability | Caco2- | 0.7432 |
| P-glycoprotein Substrate | Substrate | 0.6934 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8863 |
| Non-inhibitor | 0.8724 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8301 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3610 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.9002 |
| CYP450 2D6 Substrate | Non-substrate | 0.8161 |
| CYP450 3A4 Substrate | Non-substrate | 0.5000 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9029 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9897 |
| Non-inhibitor | 0.8950 |
| AMES Toxicity | Non AMES toxic | 0.7495 |
| Carcinogens | Non-carcinogens | 0.8549 |
| Fish Toxicity | High FHMT | 0.9724 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9239 |
| Honey Bee Toxicity | Low HBT | 0.6562 |
| Biodegradation | Not ready biodegradable | 0.9911 |
| Acute Oral Toxicity | IV | 0.6139 |
| Carcinogenicity (Three-class) | Non-required | 0.4662 |